Among them, the programmed-death receptor (PD-1) pathway was evaluated in GCT patients, with several studies demonstrating that programmed-death ligand 1 (PD-L1) and CTLA4 are frequently expressed in GCTs [54,55,56,57]. Here, CTLA4 is linked to granular cell tumor.